Summary
13 mammalian species are classified into 3 clearcut groups with respect to the stereospecific serum proteinbinding of phenprocoumon: 2 groups showing opposed stereospecific binding characteristics and a 3rd group exhibiting no stereospecific binding. Structural differences in the albumin molecule account for these stereospecific differences in serum protein-binding.
Similar content being viewed by others
References
D. T. Witiak and M. W. Whitehouse, Biochem. Pharmac.18, 971 (1969).
E. M. Sellers and J. Koch-Weser, Pharmac. Res. Commun.7, 331 (1975).
W. E. Müller and U. Wollert, Molec. Pharmac.11, 52 (1975).
A. Yacobi and G. Levy, J. Pharmacokin. Biopharm.5, 123 (1977).
W. E. Müller and U. Wollert, Res. Commun. chem. Path. Pharmac.9, 413 (1974).
W. Schmidt and E. Jähnchen, J. Pharm. Pharmac.29, 266 (1977).
E. M. Sellers, M. L. Lang-Sellers and J. Koch-Weser, J. Biochem. Pharmac.26, 2445 (1977).
N. A. Brown, E. Jähnchen, W. E. Müller and U. Wollert, Molec. Pharmac.13, 70 (1977).
E. Jähnchen, T. Meinertz, H. J. Gilfrich, U. Groth and A. Martini, Clin. Pharmac. Ther.20, 342 (1976).
J. B. West and K. Link, J. heterocycl. Chem.2, 93 (1965).
R. A. O'Reilly, Clin. Pharmac. Ther.16, 348 (1974).
A. Breckenridge, M. Orme, H. Wesseling and J. R. Lewis, Clin. Pharmac. Ther.15, 424 (1974).
D. S. Hewick and J. McEwen, J. Pharm. Pharmac.25, 458 (1973).
A. Breckenridge and M. Orme, Life Sci.11, 337 (1972).
A. Yacobi and G. Levy, J. Pharmacokin. Biopharm.2, 239 (1974).
Author information
Authors and Affiliations
Additional information
This research was supported by a grant from the Deutsche Forschungsgemeinschaft (Ja/185/6).
Rights and permissions
About this article
Cite this article
Schmidt, W., Jähnchen, E. Species-dependent stereospecific serum protein binding of the oral anticoagulant drug phenprocoumon. Experientia 34, 1323–1325 (1978). https://doi.org/10.1007/BF01981447
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF01981447